(Q30321005)

17 June 2017

Pretreatment with potent P-glycoprotein ligands may increase intestinal secretion in rats (English)

1 reference

17 June 2017

Hanafy A

1

1 reference

17 June 2017

Langguth P

series ordinal

2

1 reference

17 June 2017

Spahn-Langguth H

series ordinal

3

1 reference

17 June 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

European Journal of Pharmaceutical Sciences

17 June 2017

1 reference

17 June 2017

12

1 reference

17 June 2017

4

1 reference

17 June 2017

405-415

1 reference

P-Glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels.

17 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR?

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

Dose-effect and kinetic-dynamic relationships of the beta-adrenoceptor blocking properties of various doses of talinolol in healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

Radioligand-binding assay employing P-glycoprotein-overexpressing cells: testing drug affinities to the secretory intestinal multidrug transporter.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

Drug absorption. I. An in situ rat gut technique yielding realistic absorption rates

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

Comparison between permeability coefficients in rat and human jejunum

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

Verapamil suppresses the emergence of P-glycoprotein-mediated multi-drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

Biochemistry of multidrug resistance mediated by the multidrug transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

Modulation of vinblastine cytotoxicity by dilantin (phenytoin) or the protein phosphatase inhibitor okadaic acid involves the potentiation of anti-mitotic effects and induction of apoptosis in human tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

Inducing properties of rifampicin and rifabutin for selected enzyme activities of the cytochrome P-450 and UDP-glucuronosyltransferase superfamilies in female rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

Overexpression of P-glycoprotein in heat- and/or drug-resistant hepatoma variants

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

A general pattern for substrate recognition by P-glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

Predicting fraction dose absorbed in humans using a macroscopic mass balance approach

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

Enantiospecific high-performance liquid chromatographic assay with fluorescence detection for the monoamine oxidase inhibitor tranylcypromine and its applicability in pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

Improved Enantiospecific RP-HPLC Assays for Propranolol in Plasma and Urine with Pronethalol as Internal Standard

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

P-glycoprotein binding and modulation of the multidrug-resistant phenotype by estramustine

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

Induction of broad drug resistance in small cell lung cancer cells and its reversal by paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

Effect of colchicine and heat shock on multidrug resistance gene and P-glycoprotein expression in rat liver.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

Evidence for intestinal secretion as an additional clearance pathway of talinolol enantiomers: concentration- and dose-dependent absorption in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

In vivo and in vitro pharmacokinetics and metabolism of vincaalkaloids in rat. II. Vinblastine and vincristine

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900195-0

7 January 2021

10.1016/S0928-0987(00)00195-0

Identifiers

DOI

1 reference

17 June 2017

1 reference